Document Detail

Melanocortin signalling and the regulation of blood pressure in human obesity.
MedLine Citation:
PMID:  21062377     Owner:  NLM     Status:  In-Process    
Obesity has reached epidemic proportions worldwide. Sympathetic nervous system activation has been shown to play a major role linking obesity to the development of associated metabolic complications, such as hypertension. Recent evidence has implicated central melanocortin signalling in the regulation of blood pressure in rodents and humans. The importance of sympathetic neural activity in mediating this association has been highlighted. Humans with loss-of-function mutations in the melanocortin 4 receptor (MC4R) are an ideal group of subjects in whom the importance of melanocortin signalling in linking obesity to hypertension can be studied. Consistent with rodent studies, it was recently demonstrated that humans with MC4R deficiency have lower blood pressure, less hypertension, lower 24-h urinary catecholamine excretion, lower resting heart rate and attenuated insulin-mediated sympathetic activation compared to equally-obese humans. In overweight and obese humans without MC4R mutations, the infusion of a highly-selective MC4R agonist led to dose-dependent increases in blood pressure and heart rate. All effects were independent of insulin. This evidence supports the notion that the melanocortin system regulates blood pressure and sympathetic neural function. The results obtained in rodent and human studies, in relation to blood pressure and sympathetic function, may limit the use of MC4R agonists for the treatment of obesity. Future studies will determine whether MC4R deficiency is associated with protection from development of the detrimental cardiovascular consequences that accompany obesity.
J R Greenfield
Related Documents :
7399637 - The minneapolis childrn's blood pressure study. part 2: multiple determinants of childr...
9060907 - Left atrial size in hypertensive men: influence of obesity, race and age. department of...
6407317 - Neuromechanical properties in obese patients during carbon dioxide rebreathing.
15520317 - Alterations of left ventricular myocardial characteristics associated with obesity.
15071387 - Alveolar recruitment in combination with sufficient positive end-expiratory pressure in...
17287837 - Endothelial function in normotensive and high-normal hypertensive subjects.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of neuroendocrinology     Volume:  23     ISSN:  1365-2826     ISO Abbreviation:  J. Neuroendocrinol.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8913461     Medline TA:  J Neuroendocrinol     Country:  England    
Other Details:
Languages:  eng     Pagination:  186-93     Citation Subset:  IM    
Copyright Information:
© 2011 The Author. Journal of Neuroendocrinology © 2011 Blackwell Publishing Ltd.
Garvan Institute of Medical Research, St. Vincent's Hospital and University of New South Wales, Sydney, NSW, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Varied mechanisms of oestradiol-mediated regulation of dopamine ?-hydroxylase transcription.
Next Document:  Blocking dopamine D2 receptors by haloperidol curtails the beneficial impact of calorie restriction ...